Recherche scientifique et idées reçues

CAMBRIDGE – Après ma thèse en 1974, j'ai eu la chance extraordinaire de travailler avec Judah Folkman de la faculté de médecine de Harvard. Le Dr Folkman pensait que la progression des tumeurs pouvait être bloquée en supprimant leur source d'alimentation. Il a émis l'hypothèse selon laquelle les tumeurs produisent une substance appelée facteur angiogénique tumoral qui induit la croissance des vaisseaux sanguins à proximité, leur fournit des nutriments et les "nettoit". Il pensait que ce processus, l'angiogenèse, est d'une importance cruciale pour la survie de la tumeur.

Cette théorie allait à l'encontre des idées reçues. Les scientifiques qui ont examiné les demandes de subvention de Folkman ont dit que l'apparition de nouveaux vaisseaux sanguins était simplement due à une inflammation, et non au facteur angiogénique tumoral. Mais Folkman a persévéré et a finalement démontré que cette substance existe. Aujourd'hui, 40 ans après, ce type de substance a permis de traiter plus de 10 millions de personnes atteintes de maladies néovasculaires telle la dégénérescence maculaire et de nombreuses formes de cancer.

J'ai vécu une expérience analogue alors que je travaillais dans son laboratoire. Je cherchais à isoler les premiers inhibiteurs de la croissance des vaisseaux sanguins (des substances de poids moléculaire élevé). Il fallait pour cela développer un test d'activité biologique pour observer l'inhibition de la croissance des vaisseaux sanguins.

To continue reading, please log in or enter your email address.

Registration is quick and easy and requires only your email address. If you already have an account with us, please log in. Or subscribe now for unlimited access.

required

Log in

http://prosyn.org/L2vXaEP/fr;
  1. Chris J Ratcliffe/Getty Images

    The Brexit Surrender

    European Union leaders meeting in Brussels have given the go-ahead to talks with Britain on post-Brexit trade relations. But, as European Council President Donald Tusk has said, the most difficult challenge – forging a workable deal that secures broad political support on both sides – still lies ahead.

  2. The Great US Tax Debate

    ROBERT J. BARRO vs. JASON FURMAN & LAWRENCE H. SUMMERS on the impact of the GOP tax  overhaul.


    • Congressional Republicans are finalizing a tax-reform package that will reshape the business environment by lowering the corporate-tax rate and overhauling deductions. 

    • But will the plan's far-reaching changes provide the boost to investment and growth that its backers promise?


    ROBERT J. BARRO | How US Corporate Tax Reform Will Boost Growth

    JASON FURMAN & LAWRENCE H. SUMMERS | Robert Barro's Tax Reform Advocacy: A Response

  3. Murdoch's Last Stand?

    Rupert Murdoch’s sale of 21st Century Fox’s entertainment assets to Disney for $66 billion may mark the end of the media mogul’s career, which will long be remembered for its corrosive effect on democratic discourse on both sides of the Atlantic. 

    From enabling the rise of Donald Trump to hacking the telephone of a murdered British schoolgirl, Murdoch’s media empire has staked its success on stoking populist rage.

  4. Bank of England Leon Neal/Getty Images

    The Dangerous Delusion of Price Stability

    Since the hyperinflation of the 1970s, which central banks were right to combat by whatever means necessary, maintaining positive but low inflation has become a monetary-policy obsession. But, because the world economy has changed dramatically since then, central bankers have started to miss the monetary-policy forest for the trees.

  5. Harvard’s Jeffrey Frankel Measures the GOP’s Tax Plan

    Jeffrey Frankel, a professor at Harvard University’s Kennedy School of Government and a former member of President Bill Clinton’s Council of Economic Advisers, outlines the five criteria he uses to judge the efficacy of tax reform efforts. And in his view, the US Republicans’ most recent offering fails miserably.

  6. A box containing viles of human embryonic Stem Cell cultures Sandy Huffaker/Getty Images

    The Holy Grail of Genetic Engineering

    CRISPR-Cas – a gene-editing technique that is far more precise and efficient than any that has come before it – is poised to change the world. But ensuring that those changes are positive – helping to fight tumors and mosquito-borne illnesses, for example – will require scientists to apply the utmost caution.

  7. The Year Ahead 2018

    The world’s leading thinkers and policymakers examine what’s come apart in the past year, and anticipate what will define the year ahead.

    Order now